Design Therapeutics, Inc.DSGNNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P43
Within normal range
vs 2Y Ago
-0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -7.20% |
| Q3 2025 | 22.71% |
| Q2 2025 | 13.99% |
| Q1 2025 | -70.27% |
| Q4 2024 | -3.29% |
| Q3 2024 | 15.22% |
| Q2 2024 | 9.48% |
| Q1 2024 | 2.81% |
| Q4 2023 | 11.94% |
| Q3 2023 | -5.29% |
| Q2 2023 | 20.78% |
| Q1 2023 | -15.46% |
| Q4 2022 | -8.58% |
| Q3 2022 | -27.20% |
| Q2 2022 | 7.61% |
| Q1 2022 | -28.18% |
| Q4 2021 | -13.02% |
| Q3 2021 | 1.51% |
| Q2 2021 | -124.21% |
| Q1 2021 | -29.99% |
| Q4 2020 | -52.99% |
| Q3 2020 | -42.23% |
| Q2 2020 | 50.85% |
| Q1 2020 | 0.00% |